secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0000064803-24-000009
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health reiterates FY2024 guidance: GAAP EPS ≥$7.06, adjusted ≥$8.30
-----------------------------------------------------------------------

- Reaffirmed FY2024 GAAP diluted EPS guidance of at least $7.06.
- Reaffirmed FY2024 Adjusted EPS guidance of at least $8.30.
- Reaffirmed FY2024 cash flow from operations guidance of at least $12.0 billion.
- CFO Tom Cowhey to discuss business trends at March 5 webcast.
- Guidance unchanged; no new financial information provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480324000009/0000064803-24-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480324000009/cvs-20240305.htm
  HTML page:      https://secwatch.observer/filing/0000064803-24-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer